Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-24

FDA Approved: NEVIRAPINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for nevirapine from Camber Pharmaceuticals, approving changes to the generic product under an abbreviated new drug a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

SUPPL AP for NEVIRAPINE (NEVIRAPINE)